Compliance Investigations & White Collar

Ullman Reflects on Need for More FDA Enforcement
March 18, 2019 | Compliance Investigations & White Collar | Health Services
Marc Ullman was quoted in a NutraIngredients-USA article, “Indictment handed down in Florida over sale of SARMs, steroids.” Six people and two companies were charged by federal prosecutors for allegedly selling drugs unapproved by the FDA as supplements. “Some of these people seem to think, ‘What’s the worst that can happen to me? A warning letter? …
Read More
Rivkin Radler Attorneys Named 2019 New Jersey Super Lawyers
March 13, 2019 | Privacy, Data & Cyber Law | Trusts & Estates | Compliance Investigations & White Collar | Commercial Litigation | Insurance Fraud | Intellectual Property
HACKENSACK, NJ  – – Rivkin Radler LLP is pleased to announce that Nancy A. Del Pizzo, Jenna Gabay, and Gene Kang, have been named 2019 New Jersey Super Lawyers.  Del Pizzo was named a Top Rated Intellectual Property Litigation Attorney; and Gabay and Kang were named Rising Stars. A partner in the firm’s Commercial Litigation; …
Read More
Rivkin Radler Welcomes New Attorney
| Insurance Fraud | Compliance Investigations & White Collar
Uniondale, New York – March 2019 – Evan H. Krinick, Managing Partner of Rivkin Radler LLP, has announced that Jennifer Abreu has joined the firm as an Associate. Jennifer Abreu has joined the firm’s Compliance, Investigations & White Collar and Insurance Fraud Practice Groups. Jennifer helps insurers prosecute civil lawsuits under the federal Racketeer Influenced and …
Read More
Ullman to Participate in GMP Compliance Seminar
March 11, 2019 | Health Services | Compliance Investigations & White Collar
On April 2, Marc Ullman, along with the EAS Consulting Group, will conduct a Dietary Supplement GMP Seminar to help firms prepare for increased FDA enforcement. Given by former FDA compliance officials and industry experts, this intensive training program will provide all the information needed to comply with the rules, covering the responsibilities of domestic and …
Read More
Ullman and Shapiro Present at Supplyside East
March 8, 2019 | Compliance Investigations & White Collar
On April 10, 2019, Marc Ullman and Steven Shapiro will be featured speakers at Supplyside East, presenting on the topic, “What Is the Regulatory Current State of Play with CBD?” The pair will discuss the latest insights around regulatory issues related to cannabidiol at the international, national and local levels. Supplyside East, which bills itself …
Read More
Ullman Quoted on Future of CBD Regs upon Gottlieb’s Departure
March 6, 2019 | Compliance Investigations & White Collar
Dr. Scott Gottlieb, who announced his plan to resign as FDA commissioner on March 5, 2019, had in the previous week just announced plans to develop a regulatory framework for CBD. Marc Ullman spoke with Nutraingredients-USA about what might happen with the CBD initiative for the article entitled “Advocates hopeful that Gottlieb’s departure won’t derail …
Read More
Kaiser and Murphy to Present at Huntington Rotary Club
February 27, 2019 | Compliance Investigations & White Collar
On March 5, Geoffrey Kaiser and Casey Murphy will be speaking to the Huntington Rotary Club regarding, “The Legal Pitfalls of Running a Cash Business.” Program description: Small businesses need to be aware that certain conduct that might seem a smart business move to avoid taxes and increase profit, can be big problem and a …
Read More
Fader Quoted on OCR’s RFI regarding Changes to HIPAA
February 26, 2019 | Compliance Investigations & White Collar | Health Services
Eric Fader weighed in on an article in Healthcare Risk Management discussing the HHS Office for Civil Rights’ request for information (RFI). The RFI seeks comment on how the HIPAA Privacy Rule might be changed to allow for better coordination of care among providers. Eric noted that the Treatment, Payment, and Healthcare Operations exception to …
Read More
Ullman Quoted in NutraIngredients-USA
February 19, 2019 | Compliance Investigations & White Collar | Health Services
Marc Ullman was quoted in a NutraIngredients-USA article, “Stakeholders cautiously optimistic on Gottlieb’s proposal for info protection in NDI filings.” The comments made by the FDA Commissioner Scott Gottlieb, MD, on the NDI’s issue have made dietary supplement industry stakeholders sit up and take notice. “I’m encouraged just in that it is good to hear …
Read More
Ullman Participates in 2018 Farm Bill Webinar
February 7, 2019 | Compliance Investigations & White Collar
On March 13, 2019, Marc Ullman will be a presenter in an EAS Consulting Group webinar entitled “What Does the 2018 Farm Bill Mean for the Cannabis Industry?” The webinar will offer an informative discussion on the FDA’s position on cannabis and how the patchwork of state regulations makes the topic confusing. Accompanying Marc will …
Read More
Next Page

Get legal updates and news delivered to your inbox